Skip to main content

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen

Positions the Company to participate in fast-growing, multi-billion-dollar CAR-T immunotherapy market Recently published data suggest that HCW9206 may reduce CAR-T production costs and improve therapeutic efficacies, with the potential to support curative outcomes Company plans to commercialize the reagents through corporate partners focused on CAR-T and NK-cell therapies, including developers and manufacturers MIRAMAR, Fla., May 27, 2026 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing first-in-class fusion immunotherapeutics for autoimmune diseases, cancer, and senescence-associated dysplasia, today announced that it has exercised its option to regain full ex vivo rights to HCW9206 and HCW9201, two commercial-ready compounds as reagents, from its licensee,...

Continue reading

VenHub Opens Second, Larger Las Vegas Production Facility

Significantly Expands Manufacturing Capacity as Commercial Demand for Company’s Smart Stores Continues to Build Across Priority Verticals LAS VEGAS, May 27, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced the opening of its second and larger production and assembly facility in Las Vegas. The opening significantly expands the Company’s capacity to manufacture and deploy VenHub Smart Stores at scale. The new facility marks the next milestone in the manufacturing strategy the Company highlighted in March 2026. The opening of the facility supports faster delivery of VenHub units as demand continues to build. This milestone follows recent strategic advancements for the Company, including the extension of its agreement with LAX/Metro,...

Continue reading

Fusion Fuel Releases Investor Update Video and Investor Presentation

Reminds Shareholders of June 8, 2026 Extraordinary General Meeting to Vote on Royal Uranium Acquisition, Preferred Shares Conversion and Proposed Name Change to Fusion Elements plc Board of Directors Unanimously Recommends Shareholders Vote “FOR” All Three Resolutions Dublin, May 27, 2026 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of full-service energy engineering, advisory, and utility solutions, today released an investor update video and investor presentation. The investor presentation and accompanying investor update video provides shareholders with a strategic update on the Company’s recent progress, operational priorities, key growth targets, including the Company’s revenue and net income targets for fiscal years 2026 and 2027, and the indicative valuation...

Continue reading

Civinity to present bond issue to investors

Civinity, a group providing building maintenance services and developing engineering and technology solutions, will present the newly launched offering of a new bond issue (tranche) of up to EUR 15 million under the prospectus approved by the Bank of Lithuania on 18 July 2025 for the issuance of bonds of up to EUR 50 million (ISIN LT0000134413) and their listing on the Nasdaq regulated market. On 28 May 2026 at 11:00, Civinity Group Chief Executive Officer Tomas Staškūnas will present the bond issue to investors during a webinar. The presentation will be held in English. Investors are kindly invited to register for the webinar using the following link:https://nasdaq.zoom.us/webinar/register/WN_5b3kZtaBRsu6RxLY-0cGvQ About Civinity Civinity is a group that brings together building maintenance service providers and developers of engineering...

Continue reading

Allot to Meet Investors at the 46th Annual William Blair Growth Stock Conference on June 2, 2026

Hod Hasharon, Israel, May 27, 2026 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative Security-as-a-Service (SECaaS) and network intelligence solutions for communications service providers and enterprises, today announced that management will be meeting with investors in a one-on-one setting, at the William Blair Growth Stock Conference taking place between June 2-4, 2026, at the Loews Chicago Hotel in Chicago.   Allot’s Management will be available for meetings with institutional investors at the conference. For investors attending the conference, to schedule a meeting, please contact a William Blair representative or Allot’s investor relations team.About Allot Allot Ltd. (NASDAQ: ALLT, TASE: ALLT) is a leading provider of innovative converged cybersecurity solutions and network...

Continue reading

Goliath Resources Mobilizes For A Fully Funded 50,000 Meter Expansion Drill Program On Surebet Discovery, Golden Triangle, B.C.

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Infographic 6Infographic 6Infographic 7Infographic 7Infographic 8Infographic 8Infographic 9Infographic 9Infographic 10Infographic 10Infographic 11Infographic 11Infographic 12Infographic 12Infographic 13Infographic 13Infographic 14Infographic 14Infographic 15Infographic 15Infographic 16Infographic 16The fully funded 2026 drill program will include approximately 50,000 meters of systematic drilling designed to expand the known mineralization laterally and to depth in order to test the extent of the Surebet discovery as well as the potential location of the Motherlode...

Continue reading

Dycom Industries, Inc. Reports Record First Quarter Results and Raises Full Year Fiscal 2027 Outlook

Delivers Record First Quarter Results and Exceeds High End of Fiscal Q1 2027 OutlookRaises Full Year Fiscal 2027 OutlookAnnounces Acquisition of National Technology Integrators Further Extending Capabilities in the High-Growth Data Center Industry First Quarter Highlights(All metrics compared to the first quarter of fiscal 2026)Contract revenues of $1.965 billion(*) increased 56.1%, or 24.7% organically Net income of $91.3 million(*), or $3.00(*) per common share diluted Adjusted Net Income of $134.3 million(*), or $4.42(*) per common share diluted Adjusted EBITDA of $262.5 million(*), or 13.4% of contract revenues Total backlog of $11.906 billion(*) an increase of 46.5% Entered into a definitive agreement to acquire National Technology Integrators Repurchased 100,000 shares for $36.0 million(*) Amount represents quarterly record or...

Continue reading

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

EscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. “During the first quarter, we continued to advance both our strategic and operational priorities,” said Ofer Gonen, Chief Executive Officer of MediWound. “Enrollment continues in the EscharEx’s global Phase III VALUE study in venous leg ulcers, with more than 30 sites active...

Continue reading

Man Group PLC : Form 8.3 – Bodycote Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Bodycote plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position disclosure,...

Continue reading

PDD Holdings Announces First Quarter 2026 Unaudited Financial Results

DUBLIN and SHANGHAI, May 27, 2026 (GLOBE NEWSWIRE) — PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 HighlightsTotal revenues in the quarter were RMB106.2 billion (US$115.4 billion), an increase of 11% from RMB95.7 billion in the same quarter of 2025. Operating profit in the quarter was RMB19.6 billion (US$2.8 billion), an increase of 22% from RMB16.1 billion in the same quarter of 2025. Non-GAAP2 operating profit in the quarter was RMB21.1 billion (US$3.1 billion), an increase of 15% from RMB18.3 billion in the same quarter of 2025. Net income attributable to ordinary shareholders in the quarter was RMB12.5 billion (US$1.8 billion), a decrease of 15% from RMB14.7 billion in the same quarter of 2025....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.